Regonol (Sandoz Inc)


Welcome to the PulseAid listing for the Regonol drug offered from Sandoz Inc. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: Pyridostigmine Bromide
SUBSTANCE NAME: PYRIDOSTIGMINE BROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
ROUTE: INTRAVENOUS; PARENTERAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2005-05-10
END MARKETING DATE: 0000-00-00


Regonol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRegonol from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 2005-05-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-3040_44da988e-5709-4647-a578-ad7935601c7e
PRODUCT NDC: 0781-3040
APPLICATION NUMBER: NDA017398

Other PYRIDOSTIGMINE BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ALVOGEN INC.Pyridostigmine Bromide
American Health PackagingPyridostigmine Bromide
Bryant Ranch Prepackpyridostigmine bromide
Cadila Healthcare Limitedpyridostigmine bromide
Impax GenericsPyridostigmine Bromide
KAISER FOUNDATION HOSPITALSPyridostigmine Bromide
Major Pharmaceuticalspyridostigmine bromide
Oceanside Pharmaceuticalspyridostigmine bromide
Sandoz IncRegonol
Valeant Pharmaceuticals North America LLCMestinon
Zydus Pharmaceuticals (USA) Inc.pyridostigmine bromide